Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - Raghu, Ganesh; van den Blink, Bernt; Hamblin, Mark J; Brown, A Whitney; Golden, Jeffrey A.; Ho, Lawrence A; Wijsenbeek, Marlies S; Vasakova, Martina; Pesci, Alberto; Antin-Ozerkis, Danielle E; Meyer, Keith C; Kreuter, Michael; et al. (The lancet. Respiratory medicine, 2019)
Gesehen am 06.02.2020